¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"ABO typing"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® ABO erythroblastosis ÇÑ±Û ÀÌ¿¡ºñ¿À Àû¸ð±¸Áõ
¼³¸í   
  ÀûÇ÷±¸Ç¥¸é¿¡ Á¸ÀçÇϴ ¿©·¯ °¡Áö Ç׿øÁß¿¡¼­ A, BÇ׿øÀÌ Á¸ÀçÇÑ´Ù. À̰ÍÀ¸·Î Ç÷¾×ÇüÀ» Á¤Çϴ ¹æ¹ýÀÌ ABOÇü Ç÷¾×ÇüÀÌ´Ù. ÀÌ Ç÷¾×ÇüÀº ¸¸¾à AÇ׿øÀ» °¡Áö°í ÀÖÀ¸¸é AÇü, BÇ׿øÀ» °¡Áö°í ÀÖÀ¸¸é BÇü, ±×¸®°í A, B ¸ðµÎ¸¦ °¡Áö¸é ABÇü, ¾Æ¹« °Íµµ °¡Áö°í ÀÖÁö ¾ÊÀ¸¸é OÇüÀ¸·Î ºÐ·ù¸¦ ÇÑ´Ù. ±×¸®°í Á¤»óÀûÀ¸·Î AÇüÀÇ Ç÷¾×ÇüÀ» °¡Áø »ç¶÷¿¡°Ô´Â BÇ׿ø¿¡ ´ëÇÑ Ç×ü°¡ Á¸ÀçÇϰí BÇü Ç÷¾×ÇüÀ» °¡Áø ÀÚ¿¡°Ô´Â AÇ׿ø¿¡ ´ëÇÑ Ç×ü°¡ Á¸ÀçÇÑ´Ù. ABÇüÀÇ Ç÷¾×ÇüÀ» °¡Áø »ç¶÷¿¡°Ô´Â A, B¿¡ ´ëÇÑ Ç×ü°¡ ¸ðµÎ Á¸ÀçÇÏÁö ¾Ê°í, OÇü Ç÷¾×ÇüÀ» °¡Áø »ç¶÷¿¡°Ô´Â A, B¿¡ ´ëÇÑ µÎ°¡Áö Ç×ü°¡ ¸ðµÎ Á¸ÀçÇÑ´Ù. ÀÌ ABO Àû¸ð±¸ÁõÀº ¾î¸Ó´Ï¿Í Å¾ƻçÀÌÀÇ ÀÌ ABO Ç÷¾×ÇüÀÇ ºÎÀûÇÕÀ¸·Î ÀÎÇØ¼­ »ý±â´Â °ÍÀ¸·Î À̹̠Á¤»óÀûÀ¸·Î Á¸ÀçÇϴ Ç×ü°¡ Å¹ÝÀ» ÅëÇØ¼­ Å¾ƿ¡°Ô °Ç³Ê°¬À» °æ¿ì¿¡ »ý±ä´Ù. Áï ¾î¸Ó´Ï°¡ OÇüÀÇ Ç÷¾×ÇüÀ» °¡Á³À» °æ¿ì¿¡ ¾î¸Ó´Ï´Â Á¤»óÀûÀ¸·Î A, BÀÇ µÎ °¡Áö Ç׿ø¿¡ ´ëÇØ¼­ ¸ðµÎ Ç×ü¸¦ °¡Áö°í ÀÖ´Ù. ±×·±µ¥ Å¾ư¡ AÇüÀΠ°æ¿ì¿¡ ¾î¸Ó´Ï¿¡ Á¸ÀçÇϴ A¿¡ ´ëÇÑ Ç×ü°¡ Å¹ÝÀ» ÅëÇØ¼­ °Ç³Ê¿ÔÀ» °æ¿ì¿¡ À̰Ͱú Å¾ÆÀÇ ÀûÇ÷±¸¿¡ ºÎÂøÀÌ µÇ°í Ç×ü°¡ ºÎÂøÀÌ µÈ ÀûÇ÷±¸´Â ¿ª½Ã ÆÄ±«°¡ µÈ´Ù. ´ëºÎºÐÀÇ °æ¿ì ¾î¸Ó´Ï°¡ OÇü, ¾Æ±â°¡ AÇü, BÇüÀÏ ¶§ ÀϾ´Ù. ABOÀû¾Æ±¸ÁõÀÇ Áõ¼¼´Â Rh Àû¸ð±¸Áõº¸´Ù °¡º­¿ì³ª ÈξÀ ´õ ºó¹øÀÌ ÀϾ´Ù. ±×·¯³ª Rh Àû¾Æ±¸ÁõÀº Ã¹¹øÂ° ¾ÆÀÌ¿¡¼­ Àû°Ô »ý±â°í ´ëºÎºÐÀÇ °æ¿ì µÎ¹øÂ° ¾ÆÀÌ¿¡¼­ ¸¹ÀÌ »ý±â´Âµ¥ ºñÇÏ¿© ABO Àû¸ð±¸ÁõÀº ¾à 50%°¡ Ã¹ ¾Æ±â¿¡¼­ º¼ ¼ö ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ABO typing
    ABOÇ÷¾×Çü°Ë»ç
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ABO blood group system
    ABOÇ÷¾×Çüü°è
  • histocompatibility typing test
    Á¶Á÷ÀûÇÕ¼ºÀ¯Çü°Ë»ç
  • homozygous typing method
    µ¿Á¾Á¢ÇÕÇüº°ÆÇº°¹ý
  • primed lymphocyte typing
    ÃÊȸ¹Î°¨¸²ÇÁ±¸Çü°áÁ¤
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ABO typing
    ¿¡À̺ñ¿ÀÇ÷¾×Çü°Ë»ç
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • typing
    Çü°áÁ¤
  • serum typing
    Ç÷ûÇü°Ë»ç
  • tissue typing
    Á¶Á÷Çü°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ABO typing
    ¿¡À̺ñ¿ÀÇ÷¾×Çü°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ABO blood group system
    ¿¡À̺ñ¿ÀÇ÷¾×Çü±º
  • bacteriophage typing
    ¹ÚÅ׸®¿ÀÆÄÁöÇüº°, ¹ÚÅ׸®¿ÀÆÄÁöÇü°áÁ¤
  • complement typing
    º¸Ã¼Çüº°°Ë»ç
  • homozygous typing method
    µ¿ÇüÁ¢ÇÕ¼ºÇüº°ÆÇº°¹ý
  • leukocyte typing
    ¹éÇ÷±¸Çü°áÁ¤
  • primed lymphocyte typing
    ÃÊȸÇ׿øÀÚ±ØÈĸ²ÇÁ±¸Çüº°È­
  • primed lymphocyte-typing test
    °¨ÀÛ¸²ÇÁ±¸Çüº°°Ë»ç
  • serum typing
    Ç÷ûÇü°Ë»ç
  • typing
    Çü°áÁ¤
  • tissue typing
    Á¶Á÷Çü°Ë»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ABO typing
    ABO ±³Â÷°Ë»ç
  • ABO typing
    ABO Çüº°<Ç÷¾×Çü>°Ë»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ABO blood group=ABO system
    ABO Ç÷¾×Çü
  • Griffiths typing
    ±×¸®Çǽº ¿¬¼â±¸±ÕÇüº°°Ë»ç¹ý
  • front typing
    µ¿°áÇØµ¿ÀûÇ÷±¸
  • homozygous typing method
    µ¿ÇüÁ¢ÇÕ¼º Çüº°ÆÇº°¹ý
  • phage typing
    ÆÄÁöÇü¹ú(¡­úþܬ).
  • phage typing
    ÆÄÁöÇüº°
  • primed lymphocyte typing
    ÃÊȸÇ׿øÀÚ±ØÈÄ ¸²ÇÁ±¸Çüº°È­
  • primed lymphocyte-typing test
    ÃÊȸ°¨ÀÛ ¸²ÇÁ±¸ÀÌ¿ë Çüº°°Ë»ç
  • ABO blood group
    ABO Ç÷¾×Çü.
  • ABO blood group system
    ABOÇ÷¾×Çü°è(Åë).
  • ABO discrepancy
    ABO ºÒÀÏÄ¡
  • ABO hemolytic disease
    ABO ¿ëÇ÷¼º Áúȯ(¡­éÁúìàõ òðü´)
  • ABO hemolytic disease of the newborn
    ½Å»ý¾Æ ABO ¿ëÇ÷¼ºÁúȯ
  • ABO incompatibility
    ABOºÎÀûÇÕ.
  • ABO locus
    ABO ÁÂÀ§(¡­ñ¨êÈ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • discrepancy in ABO blood group
    ABO Ç÷¾×ÇüºÒÀÏÄ¡
  • bacteriophage typing
    ¹ÚÅ׸®¿ÀÆÄÁöÇüº°¹ý
  • bacteriophage typing
    ¼¼±ÕÆÄ¾ÆÁöÇüº°È­(úþܬûù)
  • cell typing
    Ç÷±¸Çü°Ë»ç
  • complement typing
    º¸Ã¼Çüº°È­(úþܬûù)
  • front typing
    µ¿°áÇØµ¿ÀûÇ÷±¸
  • homozygous typing method
    µ¿ÇüÁ¢ÇÕ¼º Çüº°ÆÇº°¹ý
  • phage typing
    ÆÄÁöÇüº°
  • phage typing
    ÆÄÁöÇü¹ú(¡­úþܬ).
  • primed lymphocyte typing
    ÃÊȸÇ׿øÀÚ±ØÈÄ ¸²ÇÁ±¸Çüº°È­
  • primed lymphocyte-typing test
    ÃÊȸ°¨ÀÛ ¸²ÇÁ±¸ÀÌ¿ë Çüº°°Ë»ç
  • serologic typing
    Ç÷û(ÇÐÀû) Çüº°(úìôèùÊîÜúþܬ).
  • serological typing
    Ç÷ûÇÐÀû Çüº°[°Ë»ç]
  • serum typing
    Ç÷ûÇü°Ë»ç
  • tissue typing
    Á¶Á÷Çüº°°Ë»ç
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ABO blood group (type) system
    ABOÇ÷¾×Çü (úìäûúþ) ½Ã½ºÅÛ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ABO Three Main Blood Types
ABO abortion; absent bed occupancy; American Board of Orthodontists; blood group system consisting of gr...
OAB ABO blood group; old age benefits
PLT Primed Lymphocyte Typing
BlT bleeding time; blood test; blood type, blood typing
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HTC Homozygous Typing Cell
MLST Multi Locus Sequence Typing
PLT Primed Lymphocyte Typing
SBT Sequence-based typing
SBT Sequencing Based Typing
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • ABO blood group system
    ABO Ç÷¾×Çü°è, ABO Ç÷¾×Çü °èÅë
    A, B´Â ¿ì¼º, O´Â ¿­¼ºÀ¸·Î¼­, A, B, AB, OÇüÀÌ ÀÖ´Ù.
  • ABO system
    ABO Çü, ABO °èÅë
  • blood typing
    Ç÷¾×Çü ÆÇÁ¤
  • cell typing
    Ç÷±¸Çü °Ë»ç
  • HLA typing
    ÀÎü Àӯı¸ Ç׿ø Çüº°
  • phage typing
    ÆÄ¾ÆÁö Çü¹ú, ÆäÀÌÁö Çü
    ÆÄÁö¿¡ ´ëÇÑ °¨¼ö¼º À¯¹«¿¡ µû¶ó ¼¼±ÕÀ» ºÐ·ù, Çüº°ÇÏ´Â ¹æ¹ýÀ» ÆÄÁöÇüº°À̶ó°í ÇÑ´Ù. Àü¿° °æ·Î¸¦ Á¶»çÇÏ´Â µîÀÇ ¿ªÇÐÀû ¿¬±¸¿¡ ÀÌ¿ëµÇ°í ÀÖ´Ù. ÆÄÁö °¨¼ö¼ºÀ» Á¶»çÇÏ´Â °æ¿ì¿¡´Â ÀϹÝÀûÀ¸·Î ¼¼±ÕÀ» ÆòÆÇ ¹èÁö¿¡ ½É¾î ±× À§¿¡ Àû´ç ³óµµÀÇ ÆÄÁö¾×À» ÇÑ ¹æ¿ï ¶³¾î¶ß·Á ¹è¾çÇØ¼­, ±× ºÎºÐÀÇ ¿ë±ÕÀÇ À¯¹«¿¡ ÀÇÇØ¼­ ÆÇÁ¤ÇÑ´Ù. Æ÷µµ ±¸±ÕÀÇ ÆÄÁö Çüº°À» Àß È®¸³µÇ¾î ÀÖÀ¸¸ç ¿ë±ÕÀÇ ÆÐÅÏ¿¡ µû¶ó¼­ 1, 2, 3, 4 ¹× È¥ÇÕ±ºÀ¸·Î ºÐ·ùµÇ°í ÀÖ´Ù. Çüº° ºÒ´ÉÇÑ ±ÕÁÖµµ ÀÖ´Ù. ±× ¿Ü¿¡ À导ÇÁ½º±Õ, µðÇÁÅ׸®¾Æ±Õ, ·»¼­±¸±Õ, ÄÝ·¹¶ó±Õ, Ç×»ê±Õ µî¿¡ ´ëÇØ¼­µµ ½ÃµµµÇ°í ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
ABO antigens <haematology, immunology> A system of genetically determined antigens (proteins) located on the surface of the erythrocyte.
The presence of these specific antigens gives a blood its unique properties. Because of the antigen differences existing between individuals, blood groups are significant in blood transfusions, maternal-foetal incompatibilities (erythroblastosis foetalis), tissue and organ transplantation.
(27 Sep 1997)
ABO blood group <haematology> The major human blood type system which describes the oligosaccharide glycoprotein antigens found on the surface of human blood cells.
According to the type of antigen present, a person may be assigned a blood type of A, B, AB or O. A second type of antigen, the Rh factor, renders a positive or negative blood type. The ABO blood group system is important because it determines who can donate blood to or accept blood from whom.
Type A or AB blood will cause an immune reaction in people with type B blood and type B and AB blood will cause a reaction in people with type A blood.
Conversely, type O blood has no A or B antigens, so people with type O blood are universal donors.
And since AB blood already produces both antigens, people who are type AB can accept any of the other blood types without suffering an immune reaction.
(04 Jul 1999)
ABO haemolytic disease of the newborn Erythroblastosis foetalis due to maternal-foetal incompatibility with respect to an antigen of the ABO blood group; the foetus possesses A or B antigen which is lacking in the mother, and the mother produces immune antibody which causes haemolysis of foetal erythrocytes.
(05 Mar 2000)
ABO incompatibility <haematology> A type of blood incompatibility, found rarely. Transfusion reactions may occur as a result of such incompatibility.
(27 Sep 1997)
bacterial typing techniques Procedures for identifying types and strains of bacteria. The most frequently employed typing systems are bacteriophage typing and serotyping as well as bacteriocin typing and biotyping.
(12 Dec 1998)
bacteriophage typing A technique of bacterial typing which differentiates between bacteria or strains of bacteria by their susceptibility to one or more bacteriophages.
(12 Dec 1998)
phage typing <microbiology> Bacteria may be typed by their susceptibility to a range of bacteriophages though confusion may arise if the bacteria carry plasmids encoding restriction endonucleases.
(18 Nov 1997)
mycological typing techniques Procedures for identifying types and strains of fungi.
(12 Dec 1998)
HLA typing <immunology> Tests done in order to determine if a patient has antibodies against a potential donor's HLA antigens. The presence of antibodies means that a particular graft will be rapidly rejected.
(05 Mar 2000)
DNA typing <molecular biology> See restriction fragment length polymorphism.
(18 Nov 1997)
tissue typing <procedure> The process of determining the allelic types of the antigens of the major histocompatibility complex (MHC) that determine whether a tissue graft will be accepted or rejected. at present carried out either by use of polyclonal or monoclonal antibodies against MHC antigens or less usually by tests of MHC restricted cell function or skin grafting (the latter not in humans).
(18 Nov 1997)
typing Classification according to type.
Origin: see type
Bacteriophage typing, a microbiological procedure, of epidemiological importance, for distinguishing types within a seemingly homogeneous bacterial species or strain by the use of type-specific bacteriophage.
HLA typing, tests done in order to determine if a patient has antibodies against a potential donor's HLA antigens. The presence of antibodies means that a particular graft will be rapidly rejected. Also used to establish paternity and in forensic medicine.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • typing
    ŸÀÌÇÁ¸¦ Ä¡±â
  • ABO
    Ç÷¾×Á¶Á÷ABOºÐ·ù¹ý
  • Abo-o, ab-o
    =ABORIGINAL
  • typing
    ŸÀÌÇÁ¶óÀÌÇÁÄ¡±â
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á